Embecta Corp. (EMBC)
USD 12.73
(3.66%)
USD 12.73
(3.66%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 70.4 Million USD | -68.52% |
| 2022 | 223.6 Million USD | -46.09% |
| 2021 | 414.8 Million USD | -2.99% |
| 2020 | 427.6 Million USD | -1.02% |
| 2019 | 432 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 14.7 Million USD | -49.13% |
| 2024 Q1 | 20.1 Million USD | 235.0% |
| 2024 Q2 | 28.9 Million USD | 43.78% |
| 2023 Q4 | 6 Million USD | -60.53% |
| 2023 FY | 70.4 Million USD | -68.52% |
| 2023 Q3 | 15.2 Million USD | 8.57% |
| 2023 Q2 | 14 Million USD | -60.23% |
| 2023 Q1 | 35.2 Million USD | 304.65% |
| 2022 Q1 | 98.8 Million USD | 1.75% |
| 2022 FY | 223.6 Million USD | -46.09% |
| 2022 Q4 | -17.2 Million USD | -127.56% |
| 2022 Q3 | 62.4 Million USD | -21.61% |
| 2022 Q2 | 79.6 Million USD | -19.43% |
| 2021 Q1 | 105.3 Million USD | 0.0% |
| 2021 Q4 | 97.1 Million USD | -7.26% |
| 2021 Q3 | 104.7 Million USD | -2.97% |
| 2021 FY | 414.8 Million USD | -2.99% |
| 2021 Q2 | 107.9 Million USD | 2.47% |
| 2020 FY | 427.6 Million USD | -1.02% |
| 2019 FY | 432 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | -209.24 Million USD | 133.644% |
| Theratechnologies Inc. | -23.95 Million USD | 393.86% |
| Safety Shot Inc | -15.08 Million USD | 566.749% |
| Cosmos Health Inc. | -18.54 Million USD | 479.665% |
| Cronos Group Inc. | -73.96 Million USD | 195.183% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 107.024% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 266.829% |
| Organogenesis Holdings Inc. | 4.94 Million USD | -1323.66% |
| Universe Pharmaceuticals INC | -6.16 Million USD | 1242.29% |
| ProPhase Labs, Inc. | -16.78 Million USD | 519.497% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | 1556.05% |
| Dynavax Technologies Corporation | -6.38 Million USD | 1201.894% |
| Radius Health, Inc. | -25.79 Million USD | 372.963% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | 2372.044% |
| Alvotech | -551.73 Million USD | 112.76% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | 1662.346% |
| Alpha Teknova, Inc. | -36.78 Million USD | 291.408% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 150.403% |
| SCYNEXIS, Inc. | 67.04 Million USD | -5.01% |
| Harrow Health, Inc. | -24.41 Million USD | 388.395% |
| Biofrontera Inc. | -20.13 Million USD | 449.709% |
| DURECT Corporation | -27.62 Million USD | 354.851% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | -5249.544% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | -274.887% |
| OptiNose, Inc. | -35.48 Million USD | 298.405% |
| RedHill Biopharma Ltd. | 23.91 Million USD | -194.364% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | 994.536% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | 1221.141% |
| SIGA Technologies, Inc. | 68.06 Million USD | -3.425% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | -486.032% |
| Shineco, Inc. | -22.44 Million USD | 413.599% |
| Phibro Animal Health Corporation | 2.41 Million USD | -2813.907% |
| Procaps Group S.A. | 42.54 Million USD | -65.491% |
| TherapeuticsMD, Inc. | -10.27 Million USD | 784.958% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | 1736.51% |
| Viatris Inc. | 54.7 Million USD | -28.702% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | 1662.346% |
| Rockwell Medical, Inc. | -8.43 Million USD | 934.222% |
| Incannex Healthcare Limited | -18.45 Million USD | 481.386% |
| Aytu BioPharma, Inc. | -15.84 Million USD | 544.332% |
| Tilray Brands, Inc. | -244.98 Million USD | 128.737% |
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | -46.195% |
| PetIQ, Inc. | 2.13 Million USD | -3203.613% |
| Silver Spike Investment Corp. | 7.34 Million USD | -859.114% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 71.806% |
| Journey Medical Corporation | -3.85 Million USD | 1927.148% |
| Alimera Sciences, Inc. | -20.13 Million USD | 449.692% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | 962.408% |
| Assertio Holdings, Inc. | -331.94 Million USD | 121.209% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | 1167.844% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 450.994% |
| Procaps Group, S.A. | 42.54 Million USD | -65.491% |
| PainReform Ltd. | -9.34 Million USD | 853.425% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 143.924% |
| Hempacco Co., Inc. | -13.12 Million USD | 636.337% |
| Talphera, Inc. | -18.39 Million USD | 482.671% |
| Pacira BioSciences, Inc. | 41.95 Million USD | -67.799% |
| Alvotech | -551.73 Million USD | 112.76% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 78.449% |
| Kamada Ltd. | 8.28 Million USD | -749.831% |
| Indivior PLC | 2 Million USD | -3420.0% |
| Currenc Group, Inc. | -15.3 Million USD | 559.934% |
| Evoke Pharma, Inc. | -7.79 Million USD | 1003.457% |
| Flora Growth Corp. | -57.03 Million USD | 223.431% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 450.994% |
| Evolus, Inc. | -61.68 Million USD | 214.128% |
| HUTCHMED (China) Limited | 100.78 Million USD | 30.145% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 48.817% |
| Akanda Corp. | -32.27 Million USD | 318.125% |